The provider performs a biopsy of an additional targeted lesion in the prostate using MRI–ultrasound fusion or in–bore computed tomography (CT) or magnetic resonance imaging (MRI) guidance. This is an add–on code and is reported for each additional lesion beyond the first.
For clinical responsibility, terminology, tips and additional info
start codify free trial.